Montara Therapeutics, Inc.
Dirk Landgraf is a seasoned professional in the biomedical field, currently serving as Principal at the Dementia Discovery Fund (DDF) since February 2020, previously holding the position of Vice President within the same organization. With a robust background in external innovation and business development from roles at Biogen and various board observer positions at Harness Therapeutics and TranSINE Therapeutics, Dirk possesses extensive experience in developing novel therapeutics for dementia. Academic credentials include a PhD in Systems Biology from Harvard University, complemented by a Master and Bachelor of Science in Biochemistry, Biophysics, and Molecular Biology from the Technical University of Munich. Dirk also has diverse research experience spanning postdoctoral fellowships and teaching roles at prestigious institutions.
This person is not in the org chart
This person is not in any teams
Montara Therapeutics, Inc.
1 followers
We are Montara Therapeutics, a San Francisco–based precision-medicine neuroscience biotech startup. Our team boasts significant experience from successful biotech firms such as Mitokinin, Denali, and Soteria, supported by a world-class Scientific Advisory Board (SAB). We bring a new approach to tackling challenging established targets, along with unique experience in developing enzyme activators and domain expertise in mitophagy. Our mission is to create innovative therapies for diseases of the CNS, with a focus on precision medicine and genetically validated targets to enhance drug safety and efficacy.